ClinicalTrials.gg
CompletedNCT01535079Updated Nov 12, 2012

Acute Sore Throat Pain Study

A Phase 2 interventional study of Placebo and Ibuprofen 35 mg in Acute Sore Throat Pain, sponsored by Pierre Fabre Medicament. Completed at 4 sites in 3 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-11-12.

Sponsored by Pierre Fabre Medicament (part of Pierre Fabre) · Phase 2, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
186
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 49 studies in Respiratory Tract Infections with a site in France — 18 open to participants now, 18 under way, 4 of them phase 3. Respiratory Tract Infections · France.

Enrollment
24th of 32
186 · median 301
Started
2012
with 3 others
Phase 2
4 of 49
none open now
Registered
6th of 49
by date
Lead sponsor
2 of 49
Pierre Fabre Medicament

Among the 49 studies in Respiratory Tract Infections with a site in France, this one is the 24th largest by enrollment of the 32 interventional ones that give a count, is one of 4 that started in 2012, is one of 4 in phase 2, and was the 6th registered.

Respiratory Tract Infections

753 studies on the registry are indexed under Respiratory Tract Infections; 114 are open to participants now.

Browse Respiratory Tract Infections studies →

Open to participants now

18 of the 49 studies in Respiratory Tract Infections with a site in France are open now. Recruiting first, the newest first:

13 more — sign in →

All 18 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 74 Respiratory Tract Infections studies recruiting now, 35 (47%) set no upper age limit and 31 (42%) stop at 75 or younger; 34 take children under 18; 25 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 49 studies in Respiratory Tract Infections with a site in France, or all of them as a file.
02

Study summary

"Sore throat is one of the most common complaints encountered in clinical practice. And in 65% of cases, the infection is thought to be viral in nature.

The aim of this study is to evaluate the analgesic profile of 3 Ibuprofen lozenges after single administration in acute sore throat pain."

03

Conditions studied

  • Acute Sore Throat Pain

Keywords

  • sore throat pain
  • tonsillopharyngitis
  • upper respiratory tract infection
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • male or female patients 18 years and older
  • patients with a sore throat associated or not with an Upper Respiratory Tract Infection ≥ 24 hours and ≤ 5 days duration, in the absence of Streptococcus group A

Exclusion criteria

Exclusion Criteria:

  • patients with to Ibuprofen or other NSAIDs or the .
  • patients having used analgesics or antiseptics or any topical throat treatment or any local medication containing a local oral anaesthetic within 6 hours before study entry and who use analgesics more than ≥ 3 times per week.
  • patients having used any anti inflammatory treatment or any long-acting or slow release analgesics within 12 hours before study entry
  • patients having taken antibiotics within 14 days before study entry.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Excipients

The other ingredients in a medicine besides the active drug, such as fillers, colors or preservatives.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
186 participants (actual)

Study arms

  • Placebo comparator
    Placebo

    Drug: Placebo

  • Experimental
    V0498TA01A 15 mg

    Drug: Ibuprofen 15 mg

  • Experimental
    V0498TA01A 25 mg

    Drug: Ibuprofen 25 mg

  • Experimental
    V0498TA01A 35 mg

    Drug: Ibuprofen 35 mg

  • Other
    Strefen

    Positive control

    Drug: Strefen

Interventions

06

What researchers measure

Primary outcomes

  1. Change from baseline of Sore Throat Pain Intensity Scale

    Time frame: 60 minutes

Secondary outcomes

  1. Change from baseline of Sore Throat Pain relief Scale

    Time frame: up to 360 minutes

  2. Change of Sore Throat Pain Intensity Scales

    Time frame: up to 360 minutes

  3. Local tolerability examination

    Mouth examination including extent of erythema, edema, petechial hemorrhages, ulceration (4 point scale : none, mild, moderate and severe).

    Time frame: Baseline (before drug intake) and 360 minutes

  4. General tolerability (reported adverse events)

    Time frame: Baseline (before drug intake) and 360 minutes

07

Study locations

4 sites
  • Eurofins Optimed
    Gières, France
  • Eurofins Optimed Lyon
    Pierre Bénite, France
  • Erfurt, Germany
  • Cardiff, United Kingdom
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Feb 2012, a primary completion of Nov 2012 and a completion of Nov 2012. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2012
First posted
Feb 17, 2012
Start
Feb 2012
Primary completionActual
Nov 2012
CompletionActual
Nov 2012
Last update
Nov 12, 2012
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 12, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01535079
Responsible party
Sponsor
First posted
Feb 17, 2012
Start date
Feb 2012
Primary completion
Nov 2012
Completion
Nov 2012
Last update
Nov 12, 2012
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Ibuprofen

Start the discussion